Overall Objective of This Contract Is to Advance the Development of Monovalent Vaccines for Prevention of…
FY2021 · complete year · data as of 2026-07-12
A single federal award, with both ends of the trail linked.
Award 75A50121C00077 is a contract from the Department of Health and Human Services, $95.6M obligated, FY2021 to FY2029, for Overall Objective of This Contract Is to Advance the Development of Monovalent Vaccines for…. The work is performed in New York. It is classified as NAICS 541714 (Research and Development in Biotechnology (except Nanobiotechnology)) and PSC AN42 (Health R&D Services; Health Care - Other; Applied Research). Source
Description
The Overall Objective of This Contract Is to Advance the Development of Monovalent Vaccines for Prevention of Marburg Virus (MARV) and Sudan Ebolavirus (Sudv) Disease. These Vaccines Are Based on Recombinant Expression of Filovirus Glycoproteins in